We are live on ! Find out more
BI

Berkeley Inc Portfolio holdings

AUM $298M
1-Year Est. Return 9.4%
This Fund
S&P 500
This Quarter Est. Return
+10.8%
1 Year Est. Return
+9.4%
3 Year Est. Return
+34.71%
5 Year Est. Return
+33.94%
10 Year Est. Return
AUM
$132M
AUM Growth
+$13.7M
Cap. Flow
+$1.91M
Cap. Flow %
1.44%
Top 10 Hldgs %
48.51%
Holding
82
New
5
Increased
47
Reduced
22
Closed
4

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$1.49M
2
ABBV icon
AbbVie
ABBV
+$1.01M
3
LOGI icon
Logitech
LOGI
+$547K
4
MMM icon
3M
MMM
+$219K
5
SCHW
Charles Schwab
SCHW
+$219K

Sector Composition

Rank Sector Weight
1 Financials 12.22%
2 Consumer Discretionary 10.61%
3 Healthcare 7.11%
4 Technology 3.56%
5 Industrials 3.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VYM icon
76
Vanguard High Dividend Yield ETF
VYM
$80B
$208K 0.16%
+1,920
New +$204K
VTV icon
77
Vanguard Value ETF
VTV
$186B
$204K 0.15%
+1,455
New +$200K
ADP icon
78
Automatic Data Processing
ADP
$102B
$202K 0.15%
+845
New +$207K
ABBV icon
79
AbbVie
ABBV
$450B
-7,501
Closed -$1.01M
IDLV icon
80
Invesco S&P International Developed Low Volatility ETF
IDLV
$340M
-8,200
Closed -$202K
LOGI icon
81
Logitech
LOGI
$14.8B
-11,893
Closed -$547K
SCHW
82
Charles Schwab
SCHW
$177B
-3,053
Closed -$219K

Similar funds

Berkeley Inc's Q4 2022 Portfolio in Review

As of Q4 2022, Berkeley Inc held 82 positions worth $132M, up 12% from $119M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Berkeley Inc's Q4 2022 filing shows 5 new, 47 increased, 22 reduced and 4 closed positions. Its largest new stake was Canadian Pacific Kansas City: 2,886 shares worth $215K. The largest sale was Amgen, an estimated $1.49M.

By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Berkeley Inc's largest Q4 2022 buy was Canadian Pacific Kansas City: 2,886 shares worth $215K.
  • Berkeley Inc added most to Microsoft in Q4 2022, an estimated $897K increase.
  • Berkeley Inc's biggest Q4 2022 reduction was Amgen, cutting an estimated $1.49M.
  • Berkeley Inc fully exited AbbVie in Q4 2022, selling an estimated $1.01M.
  • Berkeley Inc's ten largest holdings make up 49% of its $132M portfolio in Q4 2022.
  • Berkeley Inc opened 5 new positions and closed 4 in Q4 2022.
  • Berkeley Inc's portfolio value rose 12% quarter-over-quarter to $132M.

Based on Berkeley Inc's 13F filing for Q4 2022, filed 4 Mar 2025.